Latest stories on SLBT
SL Science Seeks FDA Orphan Drug Status for Gamma Delta T Cell Therapy in Glioblastoma
TipRanks63 · neutralgeneral
SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma
Business Insider63 · neutralproduct/pr
SL Science Highlights Strategic Shift and Major Pipeline Progress Amid Wider Losses in FY 2025
MarketChameleon54 · neutralgeneral
SL Science Holding Limited Reports Full Year 2025 Financial Results | SLBT Stock News
StockTitan28 · bearishearnings
SL Science (SLBT) Lands Nasdaq Debut With $5.57 Billion Valuation and Ambitious Cell Therapy Platform
MarketChameleon73 · bullishgeneral
Why Is SL Science Stock (SLBT) Up Today?
TipRanks63 · neutralgeneral